Evogene Ltd EVGN 深 沪
已收盘 05-15 16:00:00 美东时间
0.7325
-0.011
-1.48%
华盛通- 最 高0.75
- 今 开0.723
- 成交量 3.04万股
- 最 低 0.7063
- 昨 收 0.7435
- 总市值 886.60万
- 52周最高 2.42
- 市盈率 静 --
- 换手率 0.25%
- 52周最低 0.7063
- 委 比 0.00%
- 总股本 1210.38万
- 历史最高 203.90
- 量 比 0.63
- 振 幅 5.88%
- 历史最低 0.7063
- 每 手 1
- 风险率 0.22%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Evogene to Present at the 24th Schrödinger European User Group Meeting
Conference will be held in Munich, Germany - May 19-21, 2026 REHOVOT, Israel, May 12, 2026 /PRNewswire/ -- Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), a pioneering company in computational che...
05-12 20:00
Evogene receives Nasdaq notification
Evogene Ltd. (NASDAQ: EVGN) said on Thursday it had received a notice from the Nasdaq indicating that it had fallen out of compliance with Nasdaq Rule 5550(a)(2) after its shares had closed below $1.0...
04-03 04:09
Evogene Receives Nasdaq Noncompliance Notification, Gets Time Through Sept. 28 To Regain Compliance
Evogene Ltd. (NASDAQ:EVGN)(TASE: EVGN) (the "Company", "Evogene"), a pioneering company in computational chemistry, specializing in the generative design of small molecules for the pharmaceutical and agricultural
04-03 04:02
BRIEF-Casterra Announces Successful Commercial Field Trials In Brazil
BRIEF-Casterra Announces Successful Commercial Field Trials In Brazil March 31 (Reuters) - Evogene Ltd EVGN.TA : CASTERRA ANNOUNCES SUCCESSFUL COMMERCIAL FIELD TRIALS IN BRAZIL, POSITIONING CASTOR OIL AS A PROMISING CANDIDATE FOR ECONOMICALLY VIABLE BIOFUEL FEEDSTOCK Source text: ID:nPn3XGbj1a Furth
03-31 20:32
Evogene Earnings Call: AI Ambition Meets Cash Reality
Evogene Ltd. (($EVGN)) has held its Q4 earnings call. Read on for the main high...
03-07 08:30
Evogene shares are trading lower after the company reported a Q4 EPS miss.
Evogene shares are trading lower after the company reported a Q4 EPS miss.
03-06 00:18
Evogene Earnings Review: Q4 Summary
Evogene (NASDAQ:EVGN) reported its Q4 earnings results on Thursday, March 5, 20...
03-05 20:10
Evogene GAAP EPS of -$0.61, revenue of $0.31M
Evogene press release (EVGN): Q4 GAAP EPS of -$0.61. Revenue of $0.31M (-79.9% Y/Y). Revenues for the fourth quarter of 2025 were approximately $0.3 million; a decrease compared to approximately $1.5 ...
03-05 20:02
Earnings Scheduled For March 5, 2026
Companies Reporting Before The Bell • Palladyne AI (NASDAQ:PDYN) is projected t...
03-05 19:11
Evogene Ltd. To Focus On ChemPass AI, Streamlines Operations To Drive Long-Term Value In Pharma And AgTech
Updating on Strategic Progress and OutlookREHOVOT, Israel, Feb. 25, 2026 /PRNewswire/ -- Evogene Ltd. (NASDAQ:EVGN) (TASE: EVGN), a pioneering computational chemistry company specializing in the generative AI design
02-25 21:15
